financetom
Business
financetom
/
Business
/
PRESS DIGEST- Financial Times - March 10
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST- Financial Times - March 10
Mar 9, 2025 6:53 PM

March 10 (Reuters) - The following are the top stories

in the Financial Times. Reuters has not verified these stories

and does not vouch for their accuracy.

Headlines

- Bain and WPP ( WPP ) to break up research company Kantar

- Ukraine seeks to persuade US to resume aid in high-stakes

talks

- David Lammy vows to unlock 2.3 billion stg of frozen funds

from Chelsea sale

- Elon Musk seeks Italian presidential meeting to salvage

Starlink deal

Overview

- Market research group Kantar is set to be broken up and

sold by owners Bain Capital and WPP ( WPP ).

- Ukraine will try to persuade the U.S. to resume

intelligence and military support in high-stakes bilateral talks

this week by convincing President Donald Trump that Volodymyr

Zelenskyy wants a swift end to the war with Russia.

- UK foreign secretary David Lammy has vowed to take

"action" that could include launching a legal case in order to

free up 2.3 billion pounds ($2.97 billion) held from the sale of

Chelsea Football Club by Russian billionaire Roman Abramovich

more than two years ago.

- Elon Musk has asked to meet Italy's President Sergio

Mattarella, amid growing doubts in Rome about a potential $1.5

billion deal with Starlink, the multi-billionaire's internet

satellite provider.

($1 = 0.7732 pounds)

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Moderna Stock Wednesday?
What's Going On With Moderna Stock Wednesday?
Mar 27, 2024
Moderna Inc ( MRNA ) shares are trading higher Wednesday after the company announced that MRNA-1283 met the primary endpoints in its Phase 3 clinical trial. Additionally, Blackstone Life Sciences announced an investment to support the company’s influenza program. What Happened: Moderna ( MRNA ) held its fifth Vaccines Day event this week and announced clinical and program updates demonstrating advancement...
Kimberly-Clark to Reorganize Business Structure to Drive Growth, Cut Costs; Eyes Long-Term Targets
Kimberly-Clark to Reorganize Business Structure to Drive Growth, Cut Costs; Eyes Long-Term Targets
Mar 27, 2024
08:49 AM EDT, 03/27/2024 (MT Newswires) -- Kimberly-Clark ( KMB ) plans to optimize its margin and simplify operations in the coming months, as the company moves ahead with its bid to drive growth and reduce costs while laying out updated long-term financial targets. Ahead of its investor day on Wednesday, the maker of consumer goods such as Kleenex tissues...
Pivotree Swings to Loss in Q4, Revenue Falls; COO Steps Down to Assume SVP Role
Pivotree Swings to Loss in Q4, Revenue Falls; COO Steps Down to Assume SVP Role
Mar 27, 2024
08:49 AM EDT, 03/27/2024 (MT Newswires) -- Pivotree Inc. ( PVTRF ) , a player in frictionless commerce solutions, which saw its shares rise 2% yesterday, said Wednesday that it swung to a fourth-quarter net loss of $1.4 million, or $0.05 per basic share, from net income of $1.5 million, or $0.05 per basic share, a year earlier. Revenue for...
Timken Names Tarak Mehta President, CEO
Timken Names Tarak Mehta President, CEO
Mar 27, 2024
08:47 AM EDT, 03/27/2024 (MT Newswires) -- Timken (TKR) said Wednesday Tarak Mehta will be its next president and chief executive, effective Sept. 5. Metha will replace Richard G. Kyle, who is retiring, according to the company. Mehta is currently president of ABB's motion business, Timken said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved